Related Experiment Video

Updated: May 27, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

[Establishment of cellular immunity of enhanced hepatitis B vaccine]

Juan Wang1, Gang Wu, Li Zhao

  • 1National Vaccine & Serum Institute, Beijing, China.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology
|November 22, 2011
PubMed

Insights

This study established a method to detect cellular immune responses to an enhanced hepatitis B vaccine. The enhanced vaccine demonstrated a stronger cellular immune response compared to the standard vaccine.

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Hepatitis B remains a significant global health concern.
  • Developing enhanced vaccines is crucial for improving immune responses.
  • Cellular immunity plays a vital role in vaccine efficacy.

Purpose of the Study:

  • To establish and validate a method for detecting cellular immune responses to an enhanced hepatitis B vaccine.
  • To compare the cellular immune response elicited by the enhanced vaccine versus a normal hepatitis B vaccine.

Main Methods:

  • BALB/c mice were immunized with the enhanced hepatitis B vaccine.
  • Interferon-gamma (IFN-γ) spot-forming cells (SFC) in mouse spleen cells were detected using Elispot assay.
  • Experimental conditions were optimized, and comparisons were made between the enhanced and normal vaccines.

Main Results:

  • A higher dose (5µg) of the enhanced vaccine resulted in more IFN-γ SFC compared to a lower dose (2µg).
  • IFN-γ SFC levels decreased three weeks post-immunization.
  • Peptide stimulation yielded higher IFN-γ SFC than protein stimulation.
  • The enhanced hepatitis B vaccine induced a significantly higher IFN-γ SFC response than the normal hepatitis B vaccine.

Conclusions:

  • A reliable method for evaluating the cellular immunity of the enhanced hepatitis B vaccine was successfully established.
  • The repeatability of the detection method was confirmed.
  • The enhanced hepatitis B vaccine shows potential for eliciting a superior cellular immune response.
Abstract

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Vaccinations01:51

Vaccinations

Overview
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...